CD20-directed Radiotherapeutic Antibody
- Name
- CD20-directed Radiotherapeutic Antibody
- Accession Number
- DBCAT003271
- Description
Not Available
- Drugs
Drug Drug Description Ibritumomab tiuxetan A monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope. Tositumomab A monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope. - Drugs & Drug Targets
Drug Target Type Ibritumomab tiuxetan B-lymphocyte antigen CD20 target Tositumomab B-lymphocyte antigen CD20 target Tositumomab Low affinity immunoglobulin gamma Fc region receptor II-b target